# Arvind Bagga

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/arvind-bagga/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,531 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 64 |
| i10-index | 222 |
| Last Known Institution | All India Institute of Medical Sciences |
| OpenAlex ID | https://openalex.org/A5069538810 |
| ORCID iD | https://orcid.org/0000-0002-7832-684X |
| Works | 489 |

## Researcher papers

- [Acute kidney injury: an increasing global concern](https://scholariq.org/papers/acute-kidney-injury-an-increasing-global-concern/)
- [Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference](https://scholariq.org/papers/atypical-hemolytic-uremic-syndrome-and-c3-glomerulopathy-conclusions-from-a/)
- [IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome](https://scholariq.org/papers/ipna-clinical-practice-recommendations-for-the-diagnosis-and-management-of-2/)
- [Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/management-and-treatment-of-glomerular-diseases-part-1-conclusions-from-a-kidney/)
- [Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children](https://scholariq.org/papers/prompt-plasma-exchanges-and-immunosuppressive-treatment-improves-the-outcomes-of/)
- [Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome](https://scholariq.org/papers/efficacy-and-safety-of-treatment-with-rituximab-for-difficult-steroid-resistant/)
- [Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/management-and-treatment-of-glomerular-diseases-part-2-conclusions-from-a-kidney/)
- [Atypical Hemolytic‐Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment](https://scholariq.org/papers/atypical-hemolytic-uremic-syndrome-an-update-on-pathophysiology-diagnosis-and/)
- [The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/the-role-of-complement-in-kidney-disease-conclusions-from-a-kidney-disease/)
- [Mutations in six nephrosis genes delineate a pathogenic pathway amenable to treatment](https://scholariq.org/papers/mutations-in-six-nephrosis-genes-delineate-a-pathogenic-pathway-amenable-to/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions-2/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)

## Researcher university

- [All India Institute of Medical Sciences](https://scholariq.org/institutions/all-india-institute-of-medical-sciences/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.